duvelisib (Copiktra)

From Aaushi
Jump to navigation Jump to search

Indications

Adverse effects

Mechanism of action

More general terms

References

  1. Ingram I Duvelisib OK'd for Three Blood Cancers Drug will need to separate itself from previous PI3K inhibitor. MedPage Today. September 24, 2018 https://www.medpagetoday.com/hematologyoncology/leukemia/75292
  2. 2.0 2.1 Worcester S FDA Warns of Increased Risk of Death With CLL, Lymphoma Drug. Medscape. June 30, 2022 https://www.medscape.com/viewarticle/976447

Database